All the latest packaging trends for life sciences, all at PACK EXPO East
Explore new packaging solutions for life sciences, all in one convenient location at PACK EXPO East, March 18 – 20 in Philadelphia.

Experimental Alopecia Pill Shows Promise

If results of a new Phase 3 study are successful, Concert Pharmaceuticals will likely submit the drug for FDA approval next year.

Concert Pharmaceutical
Concert Pharmaceuticals

If this year’s Oscars did anything, it put the severe form of hair loss known as alopecia in the limelight. The disease causes the body’s immune system to attack hair follicles, resulting in patchy hair loss, or in some cases total hair loss. Currently, there are no approved treatments for the disease. But according to a recent Boston Globe article, those afflicted with the condition have new hope in the form of a pill. An experimental treatment from Concert Pharmaceuticals has restored a near full head of hair in roughly 30-40% of people with alopecia.

The drug, known as CTP-543, was tested on a group of roughly 700 people with varying degrees of hair loss due to alopecia. The 6-month study examined how many people were able to regrow hair to cover at least 80% of their scalp. Concert met their goal for 29.6% of people who received a medium dose of the drug, and 41.5% of people who received a high dose of the drug. The team is optimistic that the numbers will increase as time goes on as some peoples hair will take longer to respond. 

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More
Discover the right packaging solutions for life sciences in Philadelphia